Meet Some of the Physicians
and Cervical Spinal Cord
Injury Patients in the
AST-OPC1 Clinical Trial
 

SEC Filings



Date Filed Type Description Filer View
November 09, 2018425Filing of certain prospectuses and communications in connection with business combination transactions 
November 09, 201810-QQuarterly report which provides a continuing view of a company's financial position 
November 09, 2018425Filing of certain prospectuses and communications in connection with business combination transactions 
November 08, 2018SC 13D/AAn amendment to a SC 13D filing 
November 08, 2018425Filing of certain prospectuses and communications in connection with business combination transactions 
November 08, 20188-KReport of unscheduled material events or corporate event 
November 08, 2018425Filing of certain prospectuses and communications in connection with business combination transactions 
October 01, 20188-KReport of unscheduled material events or corporate event 
September 18, 20188-KReport of unscheduled material events or corporate event 
August 29, 20184Statement of changes in beneficial ownership of securitiesMulroy Michael
August 09, 201810-QQuarterly report which provides a continuing view of a company's financial position 
July 27, 20184Statement of changes in beneficial ownership of securitiesMulroy Michael
June 27, 20184Statement of changes in beneficial ownership of securitiesMulroy Michael
June 25, 20184Statement of changes in beneficial ownership of securitiesScher Howard Isador
June 25, 20184Statement of changes in beneficial ownership of securitiesRICCIARDI NATALE S
June 25, 20184Statement of changes in beneficial ownership of securitiesLeBuhn Richard T.
June 25, 20184Statement of changes in beneficial ownership of securitiesCartt Stephen LaHue
June 25, 20184Statement of changes in beneficial ownership of securitiesBAILEY DON M
June 25, 20184Statement of changes in beneficial ownership of securitiesARNO ANDREW
June 25, 20188-KReport of unscheduled material events or corporate event 
<< first | prev | next | last >>
page (1 of 17)
Asterias Biotherapeutics Tel: (510) 456-3800